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Abstract
We determine how prediction methods combine with optimization methods in two-stage
knowledge-based planning (KBP) pipelines to produce radiation therapy treatment plans. We
trained two dose prediction methods, a generative adversarial network (GAN) and a random
forest (RF) with the same 130 treatment plans. The models were applied to 87 out-of-sample
patients to create two sets of predicted dose distributions that were used as input to two op-
timization models. The first optimization model, inverse planning (IP), estimates weights for
dose-objectives from a predicted dose distribution and generates new plans using conventional
inverse planning. The second optimization model, dose mimicking (DM), minimizes the sum
of one-sided quadratic penalties between the predictions and the generated plans using several
dose-objectives. Altogether, four KBP pipelines (GAN-IP, GAN-DM, RF-IP, and RF-DM) were
constructed and benchmarked against the corresponding clinical plans using clinical criteria; the
error of both prediction methods was also evaluated. The best performing plans were GAN-IP
plans, which satisfied the same criteria as their corresponding clinical plans (78%) more often
than any other KBP pipeline. However, GAN did not necessarily provide the best prediction for
the second-stage optimization models. Specifically, both the RF-IP and RF-DM plans satisfied
all clinical criteria 25% and 15% more often than GAN-DM plans (the worst performing plan-
ning), respectively. GAN predictions also had a higher mean absolute error (3.9 Gy) than those
from RF (3.6 Gy). We find that state-of-the-art prediction methods when paired with different
optimization algorithms, produce treatment plans with considerable variation in quality.
1 Introduction
Automated knowledge-based planning (KBP) is a data-driven approach that uses previous radiation
therapy treatments to generate high quality plans for patients diagnosed with cancer. KBP is
typically conceptualized as a two-stage pipeline (see Figure 1). In the first stage, a machine learning
(ML) model uses contoured CT images to predict the dose that should be delivered to a patient.
In the second stage, an optimization model uses the dose prediction from the first stage to generate
fluence maps or a set of beam apertures. In the past decade, there has been significant research
in improving KBP, focusing either on advancing the machine learning or the optimization stage
independently of each other [Wu et al., 2009, Zhu et al., 2011, Yuan et al., 2012, Appenzoller et al.,
2012, Yang et al., 2013, Shiraishi et al., 2015, Shiraishi and Moore, 2016, Kearney et al., 2018, Fan
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Figure 1: Overview of the automated knowledge-based planning pipeline.
et al., 2018, Nguyen et al., 2019]. In this work, we explore whether the interaction between the
prediction and optimization model affects the overall quality of the final plans.
Several prediction models have been developed that can accurately predict aspects of a clin-
ical dose distribution from a patient’s anatomy. Originally, these prediction models required the
engineering of useful features from patient information and only predicted simple summaries (e.g.,
desirable DVHs) that could be used to design objectives for inverse planning software [Wu et al.,
2009, Zhu et al., 2011, Yuan et al., 2012, Appenzoller et al., 2012, Yang et al., 2013, Shiraishi
et al., 2015, Shiraishi and Moore, 2016, Babier et al., 2018a]. However, modern deep learning
techniques can learn useful features in order to predict dose directly from CT images [Mahmood
et al., 2018, Kearney et al., 2018, Fan et al., 2018, Nguyen et al., 2019, Babier et al., 2019]. These
high-dimensional predictions contain more information and permit better integration into more
sophisticated automated KBP pipelines [Mahmood et al., 2018].
The dominant optimization models for KBP are inverse planning (IP) [Babier et al., 2018b]
and dose mimicking (DM) [Petersson et al., 2016]. The choice of the parameters, objectives, and
constraints in these models can lead to final treatment plans with characteristics that differ signifi-
cantly from the initial predictions. For example, a prediction model may produce dose distributions
that consistently predict excess dose to an OAR, but an optimization model with an objective to
minimize the dose to that OAR may be able to correct for this bias. As a result, prediction mod-
els that produce dose distributions with good criteria satisfaction may not necessarily produce
final plans with the same properties. Constructing effective automated KBP pipelines, therefore,
requires careful selection of both the prediction and optimization model.
In this paper, we perform the first comparison between different combinations of prediction and
optimization models in KBP; each model was previously validated in a KBP pipeline [McIntosh and
Purdie, 2017, Babier et al., 2019]. In total, we consider two dose prediction methods—a generative
adversarial network [Babier et al., 2019] and a random forest [McIntosh et al., 2017]—and two
optimization methods—inverse planning [Babier et al., 2018b] and dose mimicking [Petersson et al.,
2016]. We then evaluate the four corresponding KBP pipelines (see Figure 2) using a large dataset
of 217 patients with oropharyngeal cancer. We observe that the choice of both the prediction
and optimization model can significantly affect the quality of the final plans generated by a KBP
pipeline.
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Figure 2: Overview of the automated knowledge-based planning pipelines evaluated in this paper.
Solid lines connect the prediction and optimization methods that have been tested together in (a)
Babier et al. [2019] and (b) McIntosh et al. [2017]; dashed lines connect the methods that have not
been tested in the extant literature.
2 Methods and Material
We used CT images with contours, which highlight the regions-of-interest (ROIs), and dose dis-
tributions from clinically accepted treatment plans to train two dose prediction models that were
then tested on out-of-sample clinical plans. The resulting predicted dose distributions were then
passed through each optimization model to generate fluence-based treatment plans. Figure 2 gives
an overview of the pipelines, which were then evaluated in terms of the quality of plans they
produced.
2.1 Data
For this research ethics board approved study, we obtained plans for 217 oropharyngeal cancer
treatments delivered at a single institution with 6 MV, step-and-shoot, intensity-modulated radi-
ation therapy. All plans were prescribed 70 Gy and 56 Gy in 35 fractions to the gross disease
(PTV70) and elective target volumes (PTV56), respectively; in 130 plans there was also a pre-
scription of 63 Gy to the intermediate-risk target volume (PTV63). The organs-at-risk (OARs)
were the brainstem, spinal cord, right parotid, left parotid, larynx, esophagus, mandible, and the
limPostNeck, which is an artificial structure used to limit dose to the posterior neck.
2.2 Prediction models
We trained two state-of-the-art dose prediction models with the same 130 plans from our dataset
and used the remaining 87 for out-of-sample testing.
2.2.1 Generative adversarial network
Our conditional generative adversarial network (GAN) model [Isola et al., 2017] is based on Babier
et al. [2019] and uses two convolutional neural networks: (1) a generator that produces a dose
distribution from a contoured CT image; and (2) a discriminator that tries to differentiate between
the artificially generated dose and the actual clinical dose (see Figure 3). The generator is trained
to minimize the mean absolute difference between the artificially generated image and the ground
truth (i.e., clinical dose). The objective is regularized by the discriminator to make the output
of the generator indistinguishable from a real clinical dose distribution. We then normalize the
resulting dose generated by GAN so that it satisfies all target criteria.
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Figure 3: Overview of GAN training and testing phases.
Table 1: The features used in RF to predict the dose for each voxel.
Feature Quantity Description
Structure 11 Structure voxel is classified as (one-hot-encoded)
x-coordinate 1 Voxel’s positions on the x-axis in a slice
y-coordinate 1 Voxel’s positions on the y-axis in a slice
z-coordinate 1 Plane of voxel’s slice
ROI distance 11 Voxel’s distance from surface of each ROI
CT gray-scale 1 Voxel’s gray-scale in the CT image
GF CT gray-scale 122 Voxel’s gray-scale in CT image post GF
2.2.2 Random forest
The random forest model is a slight variation of the RF from McIntosh and Purdie [2017]. It uses
the 148 features summarized in Table 1 to predict the dose delivered to each voxel independently. Of
these features, 122 were generated by applying Gaussian filters (GFs) to the grayscale CT images.
One of the GFs was isotropic (σ = 10) and a second was the Laplacian of the Gaussian (σ = 10).
The remaining 120 filters were made from all combinations of the following four parameters: (a)
first and second order GFs; (b) σ = 4, 12, 24, 48, and 64; (c) rotations of 0, 90, 180, and 270 degrees;
and (d) rotations in each of the three axes. RF was trained to minimize the mean squared difference
between the prediction and the ground truth using the default settings of randomForestRegressor
from scikit-learn.
2.3 Optimization models
For all out-of-sample patients, the output from each prediction model was passed to both optimiza-
tion models which were solved using Gurobi 7.5. The complexity of all generated treatment plans
was constrained to a sum-of-positive-gradients (SPG) value of 55 [Craft et al., 2007]. SPG was used
since it is a convex surrogate for the physical deliverability of a plan and the parameter 55 was
chosen as it is two standard deviations above the average clinical SPG [Babier et al., 2018a]. Both
optimization models used the same set of targets T and healthy structures I. Each target t ∈ T
was a planning target volume (PTV) with a prescribed dose θt. The healthy structures contained
in I were the brainstem, spinal cord, right parotid, left parotid, larynx, esophagus, mandible, and
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limPostNeck. Each target structure t ∈ T and healthy structure i ∈ I was divided into a set of
voxels Ot and Oi, respectively.
The KBP-generated plans were delivered from nine equidistant coplanar beams at angles 0◦,
40◦, . . . , 320◦. Those beams were divided into a set of beamlets B, which make up one fluence map
at each beam angle. The relationship between the intensity wb of beamlet b and dose dv deposited
to voxel v was determined using the influence matrix Dv,b generated by the IMRTP library from A
Computational Environment for Radiotherapy Research [Deasy et al., 2003], and it is given
by
dv =
∑
b∈B
Dv,bwb.
2.3.1 Inverse planning
We followed a previously developed two-stage approach to inverse planning [Babier et al., 2018b].
In the first step, we estimate the objective weights for a conventional inverse planning model that
makes a predicted dose distribution optimal. In the second step, the estimated weights are used to
re-solve the conventional inverse planning optimization model and construct a treatment plan. The
objective to be minimized was a sum of 65 functions: seven per OAR and three per target. The
objectives for the OARs were the mean dose, maximum dose, and the average dose above 0.25, 0.50,
0.75, 0.90, and 0.975 of the maximum predicted dose to the OAR. The objectives for the target
were the maximum dose, average dose below prescription, and average dose above prescription.
2.3.2 Dose mimicking
Our dose mimicking (DM) model minimized the sum of one-sided penalties to generate a plan that
performs as close as possible to the predicted dose on several voxel- and structure-based objectives.
Two types of OAR objectives were used. The first was a voxel-based objective that minimizes the
dose dv that exceeds the predicted dose dˆv for each voxel v:
xv = max
{
0, dv − dˆv
}
, ∀v ∈ Oi,∀i ∈ I. (1)
The second was a structure-based objective that minimizes the maximum dose until it no longer
exceeds the maximum predicted dose:
yi = max
{
0, max
v∈Oi
{dv} −max
v∈Oi
{dˆv}
}
, ∀i ∈ I. (2)
Three types of target objectives were also used. The first was a voxel-based objective to minimize
the average deviation below the prescribed target dose θt, which is the average underdose to target
t. Specifically, the objective function lv penalizes dose until the plan underdose is no worse than
what was predicted for each voxel v. The objective is formulated as:
lv = max
{
0, θt − dv −max{0, θt − dv}
}
, ∀v ∈ Ot,∀t ∈ T . (3)
Similarly, the second objective was also voxel-based, however, it minimizes the average deviation
above the prescribed target dose θt, which is the average overdose to target t. Specifically, the
objective function uv penalizes dose until the plan overdose is no worse than what was predicted
for each voxel v. The objective is formulated as:
uv = max
{
0, dv − θt −max{0, dˆv − θt}
}
, ∀v ∈ Ot, ∀t ∈ T . (4)
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The final target objective was structure-based. It maximizes the minimum dose to the target until
it exceeds the minimum dose that was predicted for the target:
zt = min
{
0, min
v∈Oi
{dˆv} − min
v∈Oi
{dv}
}
, ∀t ∈ T . (5)
To form the dose mimicking optimization problem, we constructed linearized forms of equations
(1)-(5) by introducing appropriate auxiliary variables and constraints and summed those terms
in the objective function. We divided each voxel-based objective by the number of voxels in its
respective structure. The conceptual DM model is
minimize
x,y,l,u,z,w
∑
i∈I
 1
|Oi|
∑
v∈Oi
x2v + (y
i)2
+∑
t∈T
(
1
|Ot|
∑
v∈Ot
(
l2v + u
2
v
)
+ (zt)2
)
,
subject to (1)− (5),
SPG ≤ 55.
2.4 Performance analysis
We evaluated four distinct KBP pipelines based on the plans they produced; predictions were also
evaluated because they are an important intermediate step. We refer to the four sets of KBP plans
as GAN-IP, RF-IP, GAN-DM, and RF-DM. We evaluated the predicted and plan dose distributions
in terms clinical criteria, the difference in the performance of each optimization model when the
same set of predictions is used as input, and the prediction error. Details of these performance
metrics are presented below.
Criteria Satisfaction
We quantified the quality of KBP plans by how often they satisfied the same clinical criteria
presented in Table 2. Specifically, we examined how often the plans satisfied the same criteria as
the clinical plans in each class of criteria (i.e., OARs, targets, and all ROIs, which includes both
OARs and targets). Finally, we evaluated the quality of the prediction models to determine whether
criteria satisfaction in the predicted dose distribution is an early indicator of final plan quality.
Optimization performance differences
For each clinical planning criterion (Table 2), we evaluated the difference in dose between plans
generated with an identical set of predictions but a different optimization model; the differences
between the two optimization models (i.e., IP and DM) are visualized with a box plot. We then
used a two-sided Mann-Whitney U test to determine if plans generated by IP were the same (null
hypothesis) or different (alternative hypothesis) from those generated by DM for the population
of plans generated from each set of predictions. For these and all subsequent hypothesis tests,
p < 0.01 was considered significant.
Prediction performance differences
We evaluated the error of each prediction method by evaluating the median absolute difference
between the predicted and clinical dose distributions across each ROI for every out-of-sample plan.
The error is visualized with a box plot and we used a two-sided Mann-Whitney U test to determine
if GAN had the same (null hypothesis) or a different (alternative hypothesis) prediction error than
RF.
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Table 2: The planning criteria used for evaluation: D99 is the minimum dose to 99% of the structure
volume, Dmean is the mean dose to a structure, and Dmax is the maximum dose to a structure.
Structure Criteria
Brainstem Dmax ≤ 54 Gy
Spinal Cord Dmax ≤ 48 Gy
Right Parotid Dmean ≤ 26 Gy
Left Parotid Dmean ≤ 26 Gy
Larynx Dmean ≤ 45 Gy
Esophagus Dmean ≤ 45 Gy
Mandible Dmax ≤ 73.5 Gy
PTV56 D99 ≥ 53.2 Gy
PTV63 D99 ≥ 59.9 Gy
PTV70 D99 ≥ 66.5 Gy
3 Results
Criteria Satisfaction
Table 3 summarizes the performance of the predicted and plan dose distributions. RF-DM plans
achieved similar OAR criteria satisfaction to the clinical plans most often (83.9%). However, GAN-
IP plans satisfied the target criteria 28.8% more often than RF-DM plans, and achieved close
to RF-DM performance on the OAR criteria (4.6 percentage points less). Across all ROIs, the
proportion of GAN-IP plans satisfied the same criteria as the corresponding clinical plans 17%
more often than its closest competitor (RF-IP). Additionally, while GAN-IP performed better than
RF-IP, GAN-DM performed worse than RF-DM, which suggests that there is an interaction effect
between the prediction and optimization model that must be accounted for.
In Table 3, we also compare the predictions to the clinical plans. We emphasize that unlike
the generated plans, i.e., IP and DM plans, the predictions are only an intermediate step in the
KBP pipeline. Here, we found that GAN predictions exhibited poor performance on all OAR
criteria (24.1%) which we attribute to the poor performance on the mandible criteria (13.6%). The
performance of RF and GAN predictions over all target criteria was similar. Overall, RF predicted
that plans could satisfy the same criteria as the clinical plans in 78.2% of cases, which far exceeded
GAN predictions (24.1%). Most importantly, however, these results do not carry through to the
final plans. That is, only GAN-IP plans achieved the same proportion of All ROI criteria (78.2%)
that was predicted by RF.
Optimization performance differences
In Figure 4, we present a box plot to compare the quality of plans from different optimization models
when the same prediction model was used as input. The plot shows how the plans generated by IP
differ from those generated by DM in terms of the dose delivered to each clinical planning criterion
relative to the dose threshold of that criterion. On average, IP was better than DM by 2% when
GAN predictions were used as input. However, we found no difference between plans generated
by IP and DM when RF predictions were used as input. We also found that IP performed better
than DM in 69.5% and 50.8% of all evaluation criteria when the inputs were from GAN and RF,
respectively. Statistically, when the GAN predictions were used as input, the plans generated by
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Table 3: The percentage of plans that satisfied the same clinical criteria as the clinical plans. Only
IP and DM plans use the full KBP pipeline
Predictions IP plans DM plans
GAN RF GAN-IP RF-IP GAN-DM RF-DM
O
A
R
s
Brainstem 100.0 98.9 100.0 100.0 100.0 98.9
Spinal Cord 97.7 100.0 100.0 100.0 90.8 97.7
Right Parotid 64.7 64.7 94.1 76.5 76.5 82.4
Left Parotid 81.8 54.5 81.8 54.5 81.8 90.9
Larynx 71.4 89.8 91.8 87.8 81.6 93.9
Esophagus 100.0 100.0 100.0 100.0 100.0 100.0
Mandible 13.6 100.0 81.8 74.2 36.4 93.9
T
ar
g
et
s PTV56 100.0 97.8 97.8 95.7 100.0 93.5
PTV63 100.0 98.0 100.0 98.0 100.0 100.0
PTV70 100.0 100.0 100.0 98.3 98.3 58.6
A
ll
OARs 24.1 80.5 79.3 69.0 41.4 83.9
Targets 100.0 97.7 98.9 95.4 98.9 70.1
ROIs 24.1 78.2 78.2 66.7 41.4 56.3
IP and DM performed differently on the clinical criteria (p < 0.001). However, we observed no
difference (p = 0.045) when RF predictions were used as input to the optimization models. Overall,
we observed that the performance of each optimization model was dependent on the prediction
model that was used.
Prediction performance differences
In Figure 5, we present the distribution of mean absolute differences between the predicted and
clinical dose over the regions of interest (i.e., the mean absolute error between the predictions and
clinical plans). Although both models had the same median prediction error across all OARs (4.3
Gy), RF error across targets (1.3 Gy) was much lower than GAN error (3.0 Gy). Overall, GAN
predictions had higher median error across all ROIs (3.9 Gy) than RF predictions (3.6 Gy), and
these predictions errors were significantly different (p < 0.001).
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Figure 4: The difference in terms of clinical planning criteria between plans generated by IP and
DM where the input to both models are (a) GAN predictions and (b) RF predictions. Positive
differences imply that the IP plan was better than the DM plan in that criterion. The boxes
indicate median and interquartile range (IQR). Whiskers extend to the minimum of 1.5 times the
IQR and the most extreme outlier.
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Figure 5: The distribution of average dose differences between KBP prediction and clinical dose
over all ROIs. The boxes indicate median and IQR. Whiskers extend to the minimum of 1.5 times
the IQR and the most extreme outlier.
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4 Discussion
Historically, each stage of KBP has been developed in isolation with a focus on improving the
prediction stage. In this paper, we show that there are interaction effects between the prediction
and optimization stages of KBP that significantly affect the quality of the generated plans. Our
experimental setup consists of four KBP pipelines that were assembled from two existing KBP
methods, i.e., Babier et al. [2019] and McIntosh et al. [2017] (see Figure 2). Overall, the best
performing combination of prediction and optimization methods was the GAN and IP. However,
we also demonstrate that predictions that produce good plans with one optimization model (e.g.,
GAN-IP) do not always produce good plans with another optimization model (e.g., GAN-DM).
Although both RF and GAN predict 3D dose distributions, they differ in their approach. RF
predicts the dose to each voxel independently of every other voxel. In contrast, GAN predicts
the dose to all voxels simultaneously, thereby making predictions that are conditioned on the
predictions of neighboring voxels. RF generally produces predictions that are more similar to
clinical plans on summary statistics like mean absolute dose difference (Figure 5). This is likely
because GAN optimizes a regularized loss function that encourages realistic looking images. This
results in predictions that have worse performance on summary statistics as compared to a model
like RF that minimizes the squared difference between predictions and the ground truth without
regularization.
The quality of deliverable plans depends heavily on the combination of the prediction and
optimization components used to construct the KBP pipeline. For example, combining GAN and
IP results in plans that perform well on average in terms of satisfying clinical criteria. Interestingly,
the KBP pipelines that perform the best contain stages that use same order loss and objective
functions (i.e., linear-linear or quadratic-quadratic). Namely, GAN (trained with mean absolute
loss) and IP (optimized with a linear objective function) produce the best IP plans. Similarly, RF
(trained with mean squared loss) and DM (optimized with a quadratic objective function) produce
the best DM plans.
When considering OAR and target criteria satisfaction as the two key components, we observe
that there is no single two-stage KBP pipeline that dominates all others. While GAN-IP performs
at least as well as RF-IP and GAN-DM on both metrics, RF-DM outperforms GAN-IP on OAR
criteria satisfaction; we conjecture that this is because GAN predictions perform poorly on the
mandible criterion. Inverse planning includes a specific objective that minimizes the dose to the
mandible, so even if the predictions (incorrectly) assume that mandible criterion satisfaction is
unimportant, the mandible objective in IP improves mandible criterion performance. In contrast,
dose mimicking attempts to construct dose distributions that are no worse than the predictions (in
terms of Equations (1) - (5)), which generally leads to less improvement on the mandible criterion.
Due to the biased nature of GAN predictions towards the mandible, IP can help to improve the
single weak criterion with minimal expense to the criteria. On the other hand, IP is unable to
exploit any significant under-performance in RF predictions, which generally perform well across
most criteria.
A limitation of our work is that, although we identified that the prediction and optimization
stages of KBP affect the overall quality of the plans they generate, we were unable to isolate the
root cause of those effects. A second limitation is that the computational resources required for this
analysis scales exponentially with the number of prediction and optimization models considered.
As a result, it is computationally intensive to determine what existing optimization model should
be paired with a new approach to dose prediction (and vice versa).
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5 Conclusion
This study demonstrates that the performance of an automated KBP pipeline is dependent on how
well the prediction and optimization models perform together. As a result, we recommend that new
prediction methods should be tested with multiple optimization models before they are considered
to be state-of-the-art (and vice versa).
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